, Volume 35, Issue 12, pp 1631–1632 | Cite as

Thioridazine and EKG anomalies

  • B. Hine
  • L. J. Traficante
  • G. Sakalis
  • S. Gershon


Acute i.v. infusion but not daily oral administration of thioridazine-HCl in the dog produced EKG anomalies similar to those reported in psychiatric patients taking this drug. Lack of EKG effects after thioridazine-5-sulfoxide infusion and presence of anomalies after thioridazine at equivalent doses suggests further evaluation of the relationship between reported plasma levels of thioridazine and its ring-sulfoxide in association with EKG changes.


Plasma Level Oral Administration Equivalent Dose Psychiatric Patient Thioridazine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 2.
    H. G. Kelly, J. E. Fay and S. G. Laverty, Can. med. Ass. J.89, 546 (1963).PubMedGoogle Scholar
  2. 3.
    T. A. Ban and A. St. Jean, Can. med. Ass. J.91, 537 (1964).PubMedGoogle Scholar
  3. 4.
    R. L. Dillenkoffer, R. B. George, M. P. Bishop and D. M. Gallant, in: Advances in Biochemical Psychopharmacology, vol. 9, p. 487. Ed. I. S. Forrest, C. J. Carr and E. Usdin. Raven Press, New York 1974.Google Scholar
  4. 5.
    R. Axelsson, Curr. ther. Res.21, 587 (1977).Google Scholar
  5. 6.
    E. C. Dinovo, L. A. Gottschalk, R. Biener and B. R. Nandi, Proc. west. Pharmac. Soc.21, 311 (1978).Google Scholar
  6. 7.
    L. J. Traficante, B. Hine, S. Gershon and G. Sakalis, Commun. Psychopharmac.1, 407 (1977).Google Scholar

Copyright information

© Birkhäuser Verlag 1979

Authors and Affiliations

  • B. Hine
    • 1
  • L. J. Traficante
    • 1
  • G. Sakalis
    • 1
  • S. Gershon
    • 1
  1. 1.Department of PsychiatryNew York University School of MedicineNew YorkUSA

Personalised recommendations